Načítá se...
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
While a human challenge study holds the prospect of accelerating the development of a vaccine for the coronavirus SARS-CoV-2, it may be opposed due to risks of harm to participants and researchers. Given the increasing number of human deaths and severe disruption to lives worldwide, we argue that a...
Uloženo v:
| Vydáno v: | Vaccine |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269942/ https://ncbi.nlm.nih.gov/pubmed/32540271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|